Compare Sihuan Pharmaceutical Holdings Group Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
HKD 11,476 Million ()
NA (Loss Making)
NA
0.81%
-0.65
-7.60%
2.39
Revenue and Profits:
Net Sales:
203 Million
(Quarterly Results - Jun 2009)
Net Profit:
65 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.69%
0%
14.69%
6 Months
14.69%
0%
14.69%
1 Year
164.52%
0%
164.52%
2 Years
192.86%
0%
192.86%
3 Years
69.07%
0%
69.07%
4 Years
-13.68%
0%
-13.68%
5 Years
-38.81%
0%
-38.81%
Sihuan Pharmaceutical Holdings Group Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.15%
EBIT Growth (5y)
-192.02%
EBIT to Interest (avg)
7.73
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.33
Tax Ratio
10.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.59%
ROE (avg)
1.99%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.93
EV to EBIT
-23.79
EV to EBITDA
-60.16
EV to Capital Employed
6.77
EV to Sales
5.11
PEG Ratio
NA
Dividend Yield
0.68%
ROCE (Latest)
-28.46%
ROE (Latest)
-11.07%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'09 - YoY
Jun'09
Jun'08
Change(%)
Net Sales
203.30
145.00
40.21%
Operating Profit (PBDIT) excl Other Income
91.40
84.60
8.04%
Interest
0.00
0.00
Exceptional Items
-83.20
-4.10
-1,929.27%
Consolidate Net Profit
65.10
64.80
0.46%
Operating Profit Margin (Excl OI)
402.40%
525.70%
-12.33%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2009 is 40.21% vs 114.81% in Jun 2008
Consolidated Net Profit
YoY Growth in quarter ended Jun 2009 is 0.46% vs 25.10% in Jun 2008
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
2,055.90
2,536.50
-18.95%
Operating Profit (PBDIT) excl Other Income
-135.70
-128.90
-5.28%
Interest
297.60
245.60
21.17%
Exceptional Items
145.60
-1,891.70
107.70%
Consolidate Net Profit
-284.70
-2,697.40
89.45%
Operating Profit Margin (Excl OI)
-103.90%
-216.50%
11.26%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -18.95% vs -36.06% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 89.45% vs -1,061.64% in Dec 2022
About Sihuan Pharmaceutical Holdings Group Ltd. 
Sihuan Pharmaceutical Holdings Group Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






